Xerostomia: causes and treatment.
Identifieur interne : 000407 ( Main/Exploration ); précédent : 000406; suivant : 000408Xerostomia: causes and treatment.
Auteurs : Jeanette Y. Wick [États-Unis]Source :
- The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists [ 0888-5109 ] ; 2007.
Descripteurs français
- KwdFr :
- Effets secondaires indésirables des médicaments (MeSH), Humains (MeSH), Maladies auto-immunes (complications), Pilocarpine (usage thérapeutique), Quinuclidines (usage thérapeutique), Salive (métabolisme), Thiophènes (usage thérapeutique), Transplantation de moelle osseuse (effets indésirables), Xérostomie (métabolisme), Xérostomie (thérapie), Xérostomie (étiologie).
- MESH :
- effets indésirables : Maladies auto-immunes, Transplantation de moelle osseuse.
- métabolisme : Salive, Xérostomie.
- thérapie : Xérostomie.
- usage thérapeutique : Pilocarpine, Quinuclidines, Thiophènes.
- étiologie : Xérostomie.
- Effets secondaires indésirables des médicaments, Humains.
English descriptors
- KwdEn :
- Autoimmune Diseases (complications), Bone Marrow Transplantation (adverse effects), Drug-Related Side Effects and Adverse Reactions (MeSH), Humans (MeSH), Pilocarpine (therapeutic use), Quinuclidines (therapeutic use), Saliva (metabolism), Thiophenes (therapeutic use), Xerostomia (etiology), Xerostomia (metabolism), Xerostomia (therapy).
- MESH :
- chemical , therapeutic use : Pilocarpine, Quinuclidines, Thiophenes.
- adverse effects : Bone Marrow Transplantation.
- complications : Autoimmune Diseases.
- etiology : Xerostomia.
- metabolism : Saliva, Xerostomia.
- therapy : Xerostomia.
- Drug-Related Side Effects and Adverse Reactions, Humans.
Abstract
When reduced salivary flow causes perpetual dry and sticky mucosa or sticky, stringy saliva, it becomes xerostomia-not a disease, but a symptom. Up to 30% of various populations self-report dry mouth (xerostomia) or have proven low salivary flow rates. Saliva is necessary for digestion and dental health, and it may have yet-unidentified immunological roles in humans. Xerostomia can lead to digestive problems, weight loss, and accelerated dental decay. Medications-several hundred of them-can cause or exacerbate xerostomia. Cancer, autoimmune diseases, and bone marrow transplants are associated with xerostomia. Including a dentist on the treatment team is essential for residents with dry mouth. As xerostomia progresses, they should shift focus primarily to prevention, maintenance, oral comfort, and emergency treatment. In all stages, they should keep treatment noninvasive if possible.
DOI: 10.4140/tcp.n.2007.985
PubMed: 18198958
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Xerostomia: causes and treatment.</title><author><name sortKey="Wick, Jeanette Y" sort="Wick, Jeanette Y" uniqKey="Wick J" first="Jeanette Y" last="Wick">Jeanette Y. Wick</name><affiliation wicri:level="2"><nlm:affiliation>National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Cancer Institute, National Institutes of Health, Bethesda, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:18198958</idno><idno type="pmid">18198958</idno><idno type="doi">10.4140/tcp.n.2007.985</idno><idno type="wicri:Area/Main/Corpus">000395</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000395</idno><idno type="wicri:Area/Main/Curation">000395</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000395</idno><idno type="wicri:Area/Main/Exploration">000395</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Xerostomia: causes and treatment.</title><author><name sortKey="Wick, Jeanette Y" sort="Wick, Jeanette Y" uniqKey="Wick J" first="Jeanette Y" last="Wick">Jeanette Y. Wick</name><affiliation wicri:level="2"><nlm:affiliation>National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Cancer Institute, National Institutes of Health, Bethesda, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author></analytic><series><title level="j">The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists</title><idno type="ISSN">0888-5109</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Autoimmune Diseases (complications)</term><term>Bone Marrow Transplantation (adverse effects)</term><term>Drug-Related Side Effects and Adverse Reactions (MeSH)</term><term>Humans (MeSH)</term><term>Pilocarpine (therapeutic use)</term><term>Quinuclidines (therapeutic use)</term><term>Saliva (metabolism)</term><term>Thiophenes (therapeutic use)</term><term>Xerostomia (etiology)</term><term>Xerostomia (metabolism)</term><term>Xerostomia (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Effets secondaires indésirables des médicaments (MeSH)</term><term>Humains (MeSH)</term><term>Maladies auto-immunes (complications)</term><term>Pilocarpine (usage thérapeutique)</term><term>Quinuclidines (usage thérapeutique)</term><term>Salive (métabolisme)</term><term>Thiophènes (usage thérapeutique)</term><term>Transplantation de moelle osseuse (effets indésirables)</term><term>Xérostomie (métabolisme)</term><term>Xérostomie (thérapie)</term><term>Xérostomie (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Pilocarpine</term><term>Quinuclidines</term><term>Thiophenes</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Bone Marrow Transplantation</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Autoimmune Diseases</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Maladies auto-immunes</term><term>Transplantation de moelle osseuse</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Saliva</term><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Salive</term><term>Xérostomie</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Xérostomie</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Pilocarpine</term><term>Quinuclidines</term><term>Thiophènes</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Xérostomie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug-Related Side Effects and Adverse Reactions</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Effets secondaires indésirables des médicaments</term><term>Humains</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">When reduced salivary flow causes perpetual dry and sticky mucosa or sticky, stringy saliva, it becomes xerostomia-not a disease, but a symptom. Up to 30% of various populations self-report dry mouth (xerostomia) or have proven low salivary flow rates. Saliva is necessary for digestion and dental health, and it may have yet-unidentified immunological roles in humans. Xerostomia can lead to digestive problems, weight loss, and accelerated dental decay. Medications-several hundred of them-can cause or exacerbate xerostomia. Cancer, autoimmune diseases, and bone marrow transplants are associated with xerostomia. Including a dentist on the treatment team is essential for residents with dry mouth. As xerostomia progresses, they should shift focus primarily to prevention, maintenance, oral comfort, and emergency treatment. In all stages, they should keep treatment noninvasive if possible.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18198958</PMID><DateCompleted><Year>2008</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0888-5109</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>12</Issue><PubDate><Year>2007</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists</Title><ISOAbbreviation>Consult Pharm</ISOAbbreviation></Journal><ArticleTitle>Xerostomia: causes and treatment.</ArticleTitle><Pagination><MedlinePgn>985-92</MedlinePgn></Pagination><Abstract><AbstractText>When reduced salivary flow causes perpetual dry and sticky mucosa or sticky, stringy saliva, it becomes xerostomia-not a disease, but a symptom. Up to 30% of various populations self-report dry mouth (xerostomia) or have proven low salivary flow rates. Saliva is necessary for digestion and dental health, and it may have yet-unidentified immunological roles in humans. Xerostomia can lead to digestive problems, weight loss, and accelerated dental decay. Medications-several hundred of them-can cause or exacerbate xerostomia. Cancer, autoimmune diseases, and bone marrow transplants are associated with xerostomia. Including a dentist on the treatment team is essential for residents with dry mouth. As xerostomia progresses, they should shift focus primarily to prevention, maintenance, oral comfort, and emergency treatment. In all stages, they should keep treatment noninvasive if possible.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wick</LastName><ForeName>Jeanette Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Consult Pharm</MedlineTA><NlmUniqueID>9013983</NlmUniqueID><ISSNLinking>0888-5109</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011812">Quinuclidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013876">Thiophenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>01MI4Q9DI3</RegistryNumber><NameOfSubstance UI="D010862">Pilocarpine</NameOfSubstance></Chemical><Chemical><RegistryNumber>K9V0CDQ56E</RegistryNumber><NameOfSubstance UI="C059240">cevimeline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016026" MajorTopicYN="N">Bone Marrow Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010862" MajorTopicYN="N">Pilocarpine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011812" MajorTopicYN="N">Quinuclidines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013876" MajorTopicYN="N">Thiophenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014987" MajorTopicYN="N">Xerostomia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>41</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>1</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>2</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>1</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18198958</ArticleId><ArticleId IdType="doi">10.4140/tcp.n.2007.985</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><country name="États-Unis"><region name="Maryland"><name sortKey="Wick, Jeanette Y" sort="Wick, Jeanette Y" uniqKey="Wick J" first="Jeanette Y" last="Wick">Jeanette Y. Wick</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000407 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000407 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18198958
|texte= Xerostomia: causes and treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18198958" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |